Trials / Completed
CompletedNCT06968416
12-Week Efficacy Clinical Study of Serum
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- ChinaNorm · Industry
- Sex
- Female
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
65 female adult subjects will be enrolled in the study, recruited according to inclusion and non-inclusion criteria listed above. At least 40 subjects should complete the clinical evaluation and 60 subjects should complete consumer questionnaire in this 15-week study (wash-out phase for 3 weeks and treatment phase for 12 weeks). Subjects will need to refrain from using any product other than the provided test products on whole face including eye area during the 3-week wash-out phase and 12-week study treatment phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard cleanser,standard moisturizer,standard sunscreen,Investigational serum | Products Application and Usage Instruction 1. Mode of application: T-3W \~ T0 Frequency: AM: Standard cleanser + standard moisturizer + standard sunscreen PM: Standard cleanser + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products 2. Mode of application: T0 \~ T12W Frequency: AM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer + standard sunscreen PM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products Usage Instruction: Use serum \[FLA #774715 21\] 8-10 drops (0.3ml) on cleansed face and eye skin 2 times a day (AM \& PM). |
Timeline
- Start date
- 2023-08-02
- Primary completion
- 2023-11-17
- Completion
- 2023-11-17
- First posted
- 2025-05-13
- Last updated
- 2025-05-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06968416. Inclusion in this directory is not an endorsement.